Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.68B |
| 2 |
ConocoPhillips
COP
|
+$520M |
| 3 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$501M |
| 4 |
Canadian Natural Resources
CNQ
|
+$495M |
| 5 |
Waste Management
WM
|
+$465M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.47B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$6.93B |
| 3 |
NVIDIA
NVDA
|
+$1.73B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.72B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.05% |
| 3 | Industrials | 7.24% |
| 4 | Energy | 7.18% |
| 5 | Healthcare | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
AAM Low Duration Preferred and Income Securities ETF
PFLD
$414M
| $8.65M | ﹤0.01% |
446,999
-46,605
| -9% | -$917K |
|
|
CSW
2002
CSW Industrials
CSW
$5.5B
| $8.65M | ﹤0.01% |
33,191
-3,032
| -8% | -$881K |
|
2003
Vanguard Total Corporate Bond ETF
VTC
$1.72B
| $8.65M | ﹤0.01% |
112,530
+2,142
| +2% | +$166K |
|
2004
Kimbell Royalty Partners
KRP
$1.46B
| $8.63M | ﹤0.01% |
596,687
+144,644
| +32% | +$1.98M |
|
2005
Royalty Pharma
RPRX
$25.5B
| $8.63M | ﹤0.01% |
179,902
+23,479
| +15% | +$1.03M |
|
2006
State Street SPDR S&P Semiconductor ETF
XSD
$2.69B
| $8.63M | ﹤0.01% |
26,453
+10,336
| +64% | +$3.57M |
|
2007
STMicroelectronics
STM
$45.9B
| $8.61M | ﹤0.01% |
249,104
-122,499
| -33% | -$3.83M |
|
2008
VictoryShares US 500 Volatility Wtd ETF
CFA
$538M
| $8.6M | ﹤0.01% |
93,984
-1,664
| -2% | -$156K |
|
2009
Capital Group Short Duration Municipal Income ETF
CGSM
$1.55B
| $8.57M | ﹤0.01% |
326,116
+150,064
| +85% | +$3.98M |
|
2010
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
| $8.57M | ﹤0.01% |
78,075
+12,680
| +19% | +$1.44M |
|
2011
Jazz Pharmaceuticals
JAZZ
$15.9B
| $8.56M | ﹤0.01% |
45,251
+6,695
| +17% | +$1.17M |
|
|
ETW
2012
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.04B
| $8.54M | ﹤0.01% |
972,894
+22,162
| +2% | +$204K |
|
|
BPRE
2013
Bluerock Private Real Estate Fund
BPRE
| $8.54M | ﹤0.01% |
513,887
+498,394
| +3,217% | +$8.3M |
|
2014
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$336M
| $8.5M | ﹤0.01% |
528,707
+454,483
| +612% | +$7.97M |
|
2015
Invesco S&P 500 High Beta ETF
SPHB
$976M
| $8.49M | ﹤0.01% |
73,240
-10,027
| -12% | -$1.21M |
|
2016
VanEck Preferred Securities ex Financials ETF
PFXF
$2.42B
| $8.49M | ﹤0.01% |
484,045
+155,882
| +48% | +$2.82M |
|
2017
John Hancock Multifactor Developed International ETF
JHMD
$965M
| $8.49M | ﹤0.01% |
200,313
+52,226
| +35% | +$2.27M |
|
2018
Vale
VALE
$61.9B
| $8.48M | ﹤0.01% |
532,849
-199,061
| -27% | -$3.11M |
|
2019
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.95B
| $8.44M | ﹤0.01% |
177,428
+16,755
| +10% | +$803K |
|
2020
Virtus Biotech ETF
BBP
$93.8M
| $8.43M | ﹤0.01% |
101,435
+12,142
| +14% | +$998K |
|
2021
PUT
Global Payments
GPN
$23.5B
| $8.41M | ﹤0.01% |
125,000
-221,300
| -64% | -$16.3M |
|
2022
Valaris
VAL
$5.35B
| $8.38M | ﹤0.01% |
85,512
+55,640
| +186% | +$4.33M |
|
2023
ADMA Biologics
ADMA
$2.03B
| $8.37M | ﹤0.01% |
929,326
+759,984
| +449% | +$12M |
|
|
SUNC
2024
SunocoCorp LLC
SUNC
$3.94B
| $8.37M | ﹤0.01% |
135,769
+245
| +0.2% | +$13.9K |
|
2025
Schwab U.S Small- Cap ETF
SCHA
$22.5B
| $8.37M | ﹤0.01% |
287,780
-74,943
| -21% | -$2.25M |
|
Similar funds
Royal Bank of Canada's Q1 2026 Portfolio in Review
As of Q1 2026, Royal Bank of Canada held 7,979 positions worth $570B, down 7.2% from $615B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada withdrew a net $34.5B in Q1 2026, closing 550 positions and reducing 3,402 holdings. Its most notable exit was Granite Real Estate Investment Trust, an estimated $299M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Royal Bank of Canada opened a new position in Sunbelt Rentals Holdings worth $465M.
- Royal Bank of Canada's largest Q1 2026 buy was Sunbelt Rentals Holdings: 7,144,038 shares worth $465M.
- Royal Bank of Canada added most to AstraZeneca in Q1 2026, an estimated $1.68B increase.
- Royal Bank of Canada's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.47B.
- Royal Bank of Canada fully exited Granite Real Estate Investment Trust in Q1 2026, selling an estimated $299M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $570B portfolio in Q1 2026.
- Royal Bank of Canada opened 549 new positions and closed 550 in Q1 2026.
- Royal Bank of Canada's portfolio value fell 7.2% quarter-over-quarter to $570B.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.